skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I’d appreciate your opinion on the iShares MSCI South Korea ETF (EWY). I suspect I may have missed a good entry point for the S Korean market as EWY is up nearly 70% YTD as of early May, hitting record highs above $160.
This rally appears to be a "perfect storm" driven by the global semiconductor cycle and South Korean companies (notably Samsung and SK Hynix). Although a little late, before initiating a position in EWY and/or its major components, I ask your insight on:
- Technical Extension: With EWY trading significantly above its 50-day and 200-day moving averages and the RSI signaling overbought territory, do you view this as a "blow-off top" or the start of a multi-year re-rating?
- Structural Reforms: To what extent is the government's "Corporate Value-Up Program" and the reduction in the "Korea Discount" providing a permanent floor for valuations? Is this a structural inflection point that justifies buying even at these levels?
- Risk/Reward: Would you consider the high momentum but "expensive" EWY over ETFs covering other regions, e.g. China or India?
- Outlook: For a minimum 2–3-year hold, is it more likely than not that I will see a significant pullback (10-15%) before further upside, or does the AI tailwind make waiting for a "dip" in South Korean AI-related companies a losing strategy?
I am not keen on chasing performance, but I recognize the demographic and technological strength of South Korea, especially after recently attending a med and science conference there. Would you initiate a modest position now, or is EWY a "wait for a pullback" candidate in your thinking? :ao:
Read Answer Asked by Adam on May 08, 2026
Q: 2:15 PM 5/5/2026

Hello Peter.

I was quite interested to read Joseph's question today, May 5th and to study your answers and recommendations. It brought my attention the Hamilton Covered Call "MAX" ETFs which have attractive yields.

We have owned large positions in Canadian banks and utilities for decades mainly for the divided income but have never ventured to try covered calls on them so I was interested in HMAX and UMAX as a way of easing into this strategy to watch and learn about it without getting into the complexities of trading. We have always been buy-and-hold forever investors.

Questions

1. You said "Our covered call exposure is specifically to add tax-deferred income (ROC distributions)" so could you give some details on just what the distributions are and how they are taxed.... dividends, ROC, other?. Do the dividend incomes on the shares in the funds flow directly to the owner [me] as part of the distributions of the fund shares.

2. I presume that HMAX and UMAX are all Canadian for income tax purposes. Does this apply also to EMAX which is 79.7% in US? I do not want to own US stocks with all the taxation complexities and T1135.

3. Could you suggest a Canadian Covered Call ETF focused just on Canadian pipelines, midstream, and oil and gas production

Thank you........... Paul K.


Read Answer Asked by Paul on May 08, 2026
Q: What are some good Canadian companies to invest in with attractive dividend yields but where the stock has historically had a lower stock price volatility
Read Answer Asked by Stephen on May 08, 2026
Q: selkirk copper

I am interested in copper plays, have beem burned a few times, cost over runs flooding etc. I saw an ad blurp on bnn. They are starting an old mine (minto I think). How do you feel about this one? I guess if they don't increase the resource it will be a good buy Charlie, worth the risk?
Thanks
Auftar
Read Answer Asked by auftar on May 08, 2026
Q: I am considering selling CVS and moving into a higher quality holding in the health care sector with less political risk. I know you like LLY and ISRG, but I already have sufficient pharmaceutical exposure and prefer to own dividend-paying stocks inside my RRIF. I was thinking of ZTS, which is in animal health, or SYK, both of which are higher quality companies that seem to be offering good entry points near 52 week lows. On the other hand, CVS has run up nicely and the turnaround under the new CEO seems to be going well. So would you hang on to CVS or would you sell and move on? And which of ZTS and SYK would you say is the better quality long term holding? Anything I am missing?
Read Answer Asked by David on May 08, 2026
Q: Hello 5i Team,
Between RioCan and SmartCentres, which would you prefer for an income portfolio? SRU pays a larger dividend, but is there any additional risk with it compared to RioCan?
How do the payout ratios and balance sheets compare?
Many thanks,
Brian



Read Answer Asked by Brian on May 08, 2026
Q: Hello 5i,

We have a combined position of 2% with XBM (25%), MP, 25%) and REMX (50%). Is there a stock or ETF that should be added to this suite as we may be light on copper, nickel, cobalt, or other minerals for battery and AI growth. If we were to increase the combined position to 3% or 4%, would you increase one more over the others?

Thank you
D&J
Read Answer Asked by Jerry on May 08, 2026
Q: Where is Palentir headed? Of course, we've known for a long time that it's an overvalued stock; we also know it's in its DNA. But this decline continues even after excellent results, which is more than worrying. Is all this due to its partnership with Google? Can you explain the ins and outs of this relationship? Ultimately, in your opinion, should we sell or hold?

Thank you in advance for your much-appreciated insights.
Read Answer Asked by Gabriel on May 08, 2026